Global Automated Analyzers Market Size By Product (Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers), By Application (Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics), By Geographic Scope and Forecast

Automated Analyzers Market Size And Forecast

Automated Analyzers Market size was valued at USD 7.51 Billion in 2024 and is projected to reach USD 15.19 Billion by 2031, growing at a CAGR of 7.3% during the forecasted period 2024 to 2031. Recent trends of automation and integration have led to the introduction of innovative products within the market, thus driving the market. Numerous pharmaceutical and biotechnology companies are frequently using them for drug discovery targets. Industry players are competing on the idea of immunoassay system features, throughput, and menu expansion to capture business share by gaining access to hospitals and laboratories. The Global Automated Analyzers Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Automated Analyzers Market Definition

An automated analyzer may be a medical laboratory instrument that's designed to live different chemical compositions and other parameters in many collected biological samples in a fast and efficient manner, with minimal human assistance. The benefits of the above-mentioned advancements and automated analyzers are automatic data acquisition, greater process control allowing real-time automation, efficient parameter monitoring, and automatic variable adjustment. These tools also offer an analysis of a good range of samples and facilitate the immediate generation of results, reflecting their potential applications within the medical care unit, outpatient clinics, and emergency as well as surgical wards in the future.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Automated Analyzers Market Overview

The growing prevalence of infectious diseases imposes an immense difficulty on healthcare service resources. A growing number of infectious diseases are continuously driving to various health hazards, which are likely to contribute to the rising number of ESR (eosinophils sedimentation rate) tests. Moreover, major factors that are contributing towards the growth of the market include the compulsion from the respective governments and industries to comply with the regulations, and the growing demand for integrated healthcare systems. The shift from legacy systems to commercial solutions was favored by mostly all the laboratories, as these solutions provide flexible and reliable methods to manage data, resources, and workflows. These have positively anticipated propelling the growth of the global Automated Analyzers Market.

There are certain restrictions and barriers faced that will hinder the overall market growth. The factors such as the unavailability of required healthcare personnel in underdeveloped or developing regions are limiting the market growth. Also, the absence of streamlined laws in emerging economies is estimated to sluggish growth during the forecast period. Further, the high cost of analyzers and inefficient testing processes, coupled with a lack of a skilled workforce is the potential restraints hampering the overall growth of the global market. Nevertheless, the improvements in technologies and untapped potential in emerging markets offer lucrative growth opportunities.

Global Automated Analyzers Market: Segmentation Analysis

The Global Automated Analyzers Market is Segmented on the basis of Product, Application, and Geography.

Automated Analyzers Market, By Product

• Biochemistry Analyzers
• Immuno-Based Analyzers
• Hematology Analyzers
• Others

Based on Product, the market is bifurcated into Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Others. The immune-based analyzers segment holds the largest market share during the forecast period. The factors that can be attributed to increasing use due to its high sensitivity and accuracy of analyte detection resulting in accurate diagnosis are accelerating the demand for the immune-based analyzer.

Automated Analyzers Market, By Application

• Drug Discovery
• Genomics
• Proteomics
• Bio Analysis
• Clinical Diagnostics
• Others

Based on Application, the market is bifurcated into Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Others. The drug discovery segment holds the largest market share during the forecast period. The rising number of diagnostic laboratories and an increasing number of corporate hospital chains will foster market demand.

Automated Analyzers Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of regional analysis, the Global Automated Analyzers Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America holds the largest market share. The significant rise in the number of investments in research and development by the government, presence of large pharmaceutical companies with R&D labs in the region, and automation solutions adoption by hospitals and clinical diagnostic labs, and ongoing projects will boost the market in the North American region.

Key Players

• The "Global Automated Analyzers Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players are
• Thermo Fisher Scientific, Danaher, Becton Dickinson, Agilent Technologies, Siemens, Shimadzu, Honeywell International, Hudson Robotics, Synchron Lab Automation, Perkinelmer, Bio-Rad, Aurora Biomed, Eppendorf AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Key Developments

• Partnerships, Collaboration and Agreements
• In August 2020, Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems, and flow cytometry testing technology for optimal clinical laboratory performance, announced an exclusive agreement with Siemens Healthineers that grants North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.
• In February 2021, Yokogawa Electric Co., Ltd. and HIROT SUBIO SCIENCE (HBS) have signed an investment partnership agreement with the aim of expanding the use of HBS's N-NOSE cancer screening service, which detects cancer using the highly sensitive olfactory function of nematodes. Under this agreement, Yokogawa will invest in HBS to manufacture and maintain N-NOSE automated analyzers
• Acquisition & Mergers
• In February 2021, Sensirion Holding AG, a leading supplier of environmental and flow sensor solutions, completes the acquisition of Qmicro B.V., an innovative OEM supplier for miniaturized gas-analysis technologies. Qmicro, based in Enschede. With the acquisition, Sensirion expands its gas sensing portfolio from components and modules to stand-alone micro gas analyzers for industrial applications
• Product launch and Product Expansion
• In June 2021, Medical device making company Trivitron Healthcare has launched two new innovation-driven products for HbA1c and Hb variant detection. The new product includes NANO H5 & NANO H110 which are high-performance liquid chromatography analyzers for HbA1c detection in less than 3 minutes.
• In April 2021, Roche announced the launch of cobas pure integrated solutions, a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.